XRCC2 and ovarian serous carcinoma: As shown in Figure 2, increased XRCC2 mRNA was linked to prolonged PFS for serous ovarian carcinoma women, HR=0.83 (0.71-0.97), P=0.021, but was not linked to OS for serous or endometrioid ovarian carcinoma patients.